FAS Wealth Partners, Inc. - ACURA PHARMACEUTICALS INC ownership

ACURA PHARMACEUTICALS INC's ticker is ACUR and the CUSIP is 00509L802. A total of 23 filers reported holding ACURA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FAS Wealth Partners, Inc. ownership history of ACURA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$13,000
-50.0%
16,3960.0%0.00%
-55.6%
Q3 2016$26,000
-13.3%
16,3960.0%0.01%
-18.2%
Q2 2016$30,000
-34.8%
16,3960.0%0.01%
-54.2%
Q1 2016$46,000
+12.2%
16,3960.0%0.02%
+20.0%
Q4 2015$41,000
+5.1%
16,3960.0%0.02%
-9.1%
Q3 2015$39,00016,3960.02%
Other shareholders
ACURA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 1,956,397$4,598,0000.84%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,025,641$2,410,0000.09%
SABBY MANAGEMENT, LLC 743,603$1,747,0000.07%
FAS Wealth Partners, Inc. 16,396$39,0000.02%
VANGUARD GROUP INC 5,079,022$188,675,0000.01%
Spark Investment Management LLC 18,579$43,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 48,756$115,0000.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 42,838$101,0000.00%
Tower Research Capital LLC (TRC) 4,692$11,0000.00%
Asset Planning Services, Ltd. 348$1,0000.00%
View complete list of ACURA PHARMACEUTICALS INC shareholders